Various graft vs. host diseases (GvHD) in rodents can be prevented and treated by malononitrilamides (MNAs)

被引：0
|
作者：
H. U. Schorlemmer
R. Kurrle
R. R. Bartlett
机构：
[1] Research Laboratories Hoechst Marion Roussell (HMR),
[2] TA Rheumatology/Immunology,undefined
[3] c/o Behringwerke AG,undefined
[4] P.O. Box 1140,undefined
[5] D-35001 Marburg,undefined
[6] Germany,undefined
[7] Fax +49 6421 39 46 63,undefined
[8] Werk Kalle-Albert,undefined
[9] D-65174 Wiesbaden,undefined
[10] Germany,undefined
来源：
Inflammation Research | 1997年 / 46卷 / Suppl 2期
关键词：
Host Disease;
D O I：
10.1007/s000110050160
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：165 / 166
页数：1
相关论文
共 50 条
  • [1] Various graft vs. host diseases (GvHD) in rodents can be prevented and treated by malononitrilamides (MNAs)
    Schorlemmer, HU
    Kurrle, R
    Bartlett, RR
    INFLAMMATION RESEARCH, 1997, 46 : S165 - S166
  • [2] The new immunosuppressants, the malononitrilamides MNA 279 and MNA 715, inhibit various graft-vs.-host diseases (GvHD) in rodents
    Schorlemmer, HU
    Kurrle, R
    Bartlett, RR
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1997, 23 (5-6) : 167 - 173
  • [3] Malononitrilamides inhibit the development of various murine graft-vs-host diseases
    Schorlemmer, HU
    Kurrle, R
    Bartlett, RR
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (06) : 3043 - 3047
  • [4] Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides
    Schorlemmer, HU
    Schwab, W
    Ruuth, E
    Kurrle, R
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (06) : 3048 - 3050
  • [5] Graft vs. host disease: pathology, prophylaxis and therapy: GVHD overview - Preface
    Weisdorf, Daniel
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (02) : 99 - 100
  • [6] Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions
    Krieger, Elizabeth
    Toor, Amir Ahmed
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [7] Graft vs Host Disease (GVHD) in Post Liver Transplant Patient Successfully Treated With Ruxolitinib
    Ahmad, Muhammad I.
    Abughazaleh, Shaadi
    Kodali, Sudha
    Schwartz, Mary R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1270 - S1270
  • [8] Can transfusion-associated graft-versus-host disease (TA-GvHD) be prevented with leukoreduction alone?
    Rodriguez, Juan Vitelio
    Tormey, Christopher A.
    TRANSFUSION AND APHERESIS SCIENCE, 2022, 61 (02)
  • [9] Apograft, a Novel Stem Cell Selection Technology, Prevents Graft vs. Host Disease (GvHD) While Preserving Graft vs Leukemia (GvL) Effects
    Stein, Jerry
    Pinkas, Liat
    Levy-Barazany, Hilit
    Saar, Alex
    Abraham, Michal
    Mishalian, Inbal
    Wildbaum, Hila
    Katz, Tami
    Baar, Yuval
    Nechushtan, Amotz
    Pereg, Yaron
    Yarkoni, Shai
    Yaniv, Isaac
    Rowe, Jacob M.
    Peled, Amnon
    Zuckerman, Tsila
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S192 - S192
  • [10] Ixazomib for Treatment of Refractory Chronic Graft Vs. Host Disease: A Chronic Gvhd Consortium Phase II Trial
    Pidala, Joseph A.
    Bhatt, Vijaya Raj
    Hamilton, Betty K.
    Pusic, Iskra
    Wood, William A.
    Onstad, Lynn
    Hall, Anne M.
    Storer, Barry E.
    Lee, Stephanie J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
12345